Brief: Apellis Pharmaceuticals Plans To Seek Immediate Re-Examination Of Its Application

Apellis Pharmaceuticals

26/01/2024 13:10

Jan 26 (Reuters) - Apellis Pharmaceuticals Inc  APLS.O :
    * APELLIS ANNOUNCES NEGATIVE CHMP OPINION FOR PEGCETACOPLAN
FOR GA
IN THE EUROPEAN UNION AND PLANS TO SEEK RE-EXAMINATION OF
APPLICATION
    * APELLIS PHARMACEUTICALS INC - APELLIS PLANS TO SEEK
IMMEDIATE
RE-EXAMINATION OF ITS APPLICATION

Source text for Eikon:  ID:nGNX6tntC9 
Further company coverage:  APLS.O 

 ((reuters.briefs@thomsonreuters.com;))